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sustained virologic response (SVR) rates with the currently ap-
proved interferon-based therapies, these therapies are limited
by the on-treatment side effects and by the relatively inferior
response in patients with HCV genotype 1 infection. Several host
and viral factors have been implicated to inﬂuence the disease
progression and the treatment response in chronic hepatitis
C (CHC) patients, and efforts to modify these factors to the
optimize the therapeutic response are ungently needed.
Recently, host metabolic factors, such as diabetes mellitus (DM),
insulin resistance (IR), hepatic steatosis, and impaired lipid
metabolism have been found to closely associated with HCV
infection. Ample clinical evidence indicate that deranged lipid
proﬁles and hepatic steatosis correlate with HCV infection, sug-
gesting their potential roles of predicting therapeutic responses.
Furthermore, it has been demonstrated in vitro that the lipid
rafts, mainly composed of cholesterol and sphingolipid, and the
lipid droplet, an organelle for storing neutral lipids, play the cru-
tial roles of producing infectious viruses. While HCV genotypes 3
virus may directly cause hepati steatosis, the association of viral
loads in HCV genotype 1 or 2 virues, the mainly types in infected
individuals in the world, with the lipid proﬁles still remains
elusive. The search of the association between lipid proﬁles and
the HCV genotypic differences is therefore important.
A recent study recruting 531 patients with either HCV genotype
1 or 2 infection showed that high serum triglyceride, totoal
cholesterol and low-density lipoprotein (LDL) correlated with
high HCV RNA levels. In patients with low body mass index (BMI),
high modeal assessment of insulin resistance index (HOMA-IR)
and total cholesterol levels were associated with high HCV viral
load. After stratiﬁcation by HCV genotypes, lipid proﬁles were
highly associated with HCV viral load in genotype 2, rather than
genotype 1 patients. The study indicated that differed mecha-
nisms of deranged lipid proﬁles between HCV genotype 1 and
2 viruses. Because the casual relationship of the viral load and
the lipid proﬁles are still to be determined, manipulation of the
lipid proﬁles aiming in improving the anti-HCV therapy deserves
further studies.
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Despite extensive investigations, a microbiological cause cannot
be found in about half of the patients with infectious disease.
Throughout the years, scientists have spent tremendous efforts
in looking for microorganisms associated with these “unexplained
infectious disease syndromes”. In 2001, we discovered Laribac-
ter hongkongensis gen. nov. sp. nov., a facultative anaerobic,
Gram-negative, S-shaped, urease-positive rod of the Neisseri-
aceae family, from blood and empyema thoracis of a patient with
alcoholic cirrhosis. During the past eight years, we have docu-
mented that L. hongkongensis was associated with community
acquired gastroenteritis and traveler’s diarrhea and cases were
found globally in patients who resided in or had recent travel
histories to countries in Asia, Europe, America and Africa. We
have found that freshwater ﬁsh is the reservoir and it was also
found in Chinese tiger frogs and drinking water reservoirs. Due
to the potential of its clinical importance and related ecology,
important phenotypic characteristics and phylogenetic position,
and the availability of genetic manipulation systems for down-
stream experiments, we sequenced the complete genome of L.
hongkongensis, with the aim of achieving better understanding
of its biology, mechanism of adaptation to different hosts, and
virulence mechanisms. The complete genome sequence of L.
hongkongensis consists of a 3,169-kb chromosome with G+C con-
tent of 62.35%. Genome analysis reveals different mechanisms
potentially important for its adaptation to diverse habitats of hu-
man and freshwater ﬁsh intestines and freshwater environments.
The gene contents suggest that amino acids and fatty acids can
be used as carbon sources. The extensive variety of transporters
including multidrug efﬂux and heavy metal transporters, as well
as genes involved in chemotaxis may enable L. hongkongensis
to survive in different environmental niches. Genes encoding
urease, bile salts efﬂux pump, adhesin, catalase, superoxide dis-
mutase and other putative virulence factors, such as hemolysins,
RTX toxins, patatin-like proteins, phospholipase A1 and colla-
genases, are present. Proteomes of L. hongkongensis cultured
at 37°C and 20°C showed differential gene expression, includ-
ing two homologous copies of argB, argB-20 and argB-37, that
encode two isoenzymes of N-acetyl-L-glutamate kinase (NAGK),
NAGK-20 and NAGK-37, in the arginine biosynthesis pathway.
NAGK-20 showed higher expression at 20°C whereas NAGK-37
showed higher expression at 37°C. NAGK-20 also had a lower
optimal temperature for enzymatic activities and was inhibited
by arginine probably as negative feedback control. Similar du-
plicated copies of argB are also observed in bacteria from hot
springs, including Thermus thermophilus, Deinococcus geother-
malis, Deinococcus radiodurans and Roseiﬂexus castenholzii,
suggesting that similar mechanisms for temperature adaptation
may be employed by other bacteria.
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Increasing antimicrobial resistance brings difﬁculties for selec-
tion of effective antimicrobial regimens in the treatment of
bacterial infections. Antimicrobial resistance trends and ther-
apeutic options will be discussed for the following highly an-
timicrobial resistant gram-negative bacilli: ESBL-producing Es-
cherichia coli and Klebsiella pneumoniae, and multiple-resistant
Pseudomonas aeruginosa and Acinetobacter baumannii. ESBLs-
producing strains of E. coli and K. pneumoniae have been
increasing and currently approximately half of the strains pro-
duce ESBLs in China. Carbapenems produce the best outcomes
in the treatment of ESBLs infections. In vitro ESBL-producing
organisms vary in their susceptibility to other antimicrobials.
The susceptibility rates of ESBL-producing strains are relatively
high to β-lactamase inhibitor combinations such as cefoperazone-
sulbactam and piperacillin-tazobactam, which might be used in
the treatment of such infections in high dosage. The isolation
of P. aeruginosa and A. baumannii, the most common pathogens
in ventilator-associated pneumoniae (VAP), has been increas-
ing in clinical specimens. Both P. aeruginosa and A. baumannii
are non-fermenters, which are highly resistant to antimicrobial
agents. According to a bacterial surveillance program, CHINET,
in China, the resistance rates of P. aeruginosa clinical strains
to ceftazidime, piperacillin-tazobactam, imipenem, meropenem
and ciproﬂoxacin were from 21% to 30% in 2008, while the
resistance rates were relatively lower to amikacin, cefepime
and cefoperazone-sulbactam with resistance rates from 15% to
18%. Acinetobacter spp. was more resistant to most antimicro-
bials than did P. aeruginosa. The choice of antimicrobial agents
should be based on the in-vitro susceptibility results. For severe
infections, combination therapy is recommended as following:
an active β-lactam combined with an aminoglycoside or with a
quinolone such as ciproﬂoxacin or levoﬂoxacin. A. baumannii is
highly susceptible to doxycycline or minocycline, but the clinical
experience is limited. Colistin has emerged again as a thera-
peutic option for pandrug resistant (PDR) P. aeruginosa and A.
